In Vitro Diagnostic Packaging Market Poised to Hit $13.5 Billion by 2029 with Accelerating Growth Trends

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

In Vitro Diagnostic Packaging Market Size Growth Forecast: What to Expect by 2025?
Over the past few years, the in vitro diagnostic packaging market has witnessed robust growth. Its size is projected to increase from $9.37 billion in 2024 to $10.04 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%. Key factors driving the historic growth include the burgeoning demand for early disease detection, the uptick in chronic diseases, rising healare expenditure, the proliferation of diagnostic laboratories, and the expansion of point-of-care testing.

How Will the In Vitro Diagnostic Packaging Market Size Evolve and Grow by 2029?
Expectations suggest that the in vitro diagnostic packaging market will undergo considerable growth in the coming years, reaching a valuation of $13.5 billion in 2029, with a compound annual growth rate of 7.7%. A surge in personalized medicine, a growing aged population, advances in diagnostic technologies, the rising popularity of at-home testing kits, and enhanced regulatory demands for safe packaging are all factors contributing to the growth for the predicted period. Looking forward, there is an anticipation of trends such as the adoption of eco-friendly and recyclable packaging materials, the inclusion of intelligent packaging technologies, the downsizing of diagnostic kits, more widespread outsourcing of packaging services, and a higher demand for tamper-proof and sterile packaging solutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostic-packaging-global-market-report

What Drivers Are Propelling the Growth of In Vitro Diagnostic Packaging Market Forward?
The escalating occurrence and prevalence of chronic sicknesses and contagions are projected to push forward the growth of the in vitro diagnostic (IVD) packaging market. Such health conditions or diseases that are triggered by pathogens and often result in lasting medical complications. The growth in occurrence and prevalence of such health conditions can be attributed to increased exposure to pathogens, which is often influenced significantly by lifestyle choices, particularly poor dieting habits and a lack of physical exertion. The in vitro diagnostic (IVD) packaging provides solutions for chronic diseases and infections by safeguarding the secure, trustworthy, and efficient delivery of diagnostic examinations which aid in the early identification and timely curing, thus enhancing patient outcomes and the efficacy of healare. For instance, as per the data released by the UK Health Security Agency, a UK-based executive organization, in England, the UK Health Security Agency (UKHSA) reported a rise to 368 measles incidents in 2023, showing a drastic increase almost seven times the 53 incidents reported in 2022. The West Midlands and London were accountable for approximately 44% and 33% of total cases, respectively. Therefore, the escalating occurrence and prevalence of chronic sicknesses and contagions are fueling the expansion of the in vitro diagnostic packaging market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24250&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the In Vitro Diagnostic Packaging Market?
Prominent entities involved in the in vitro diagnostic packaging field are prioritising the development of novel products, for instance, the sustainable IVD packaging solution to boost overall sustainability and decrease the ecological footprint associated with diagnostic product packaging. A sustainable IVD packaging solution indicates the incorporation of green materials and methods in the packaging of diagnostic commodities, with the aim of lowering environmental impact while ensuring the product's safety and wholeness. As an illustration, Oxford Gene Technology IP Limited, a firm in the UK providing diagnostic genomic solutions, unveiled an eco-friendly packaging solution for its CytoCell range in March 2025. This cutting-edge packaging emphasises the use of biodegradable and recyclable constituents that are in line with the industry's escalating trend towards environmentally-friendly measures. The refreshed packaging not only encourages a greener way of discarding products but also eases the process for labs with simplified and readily-available digital paperwork. This measure underlines the firm's pledge to minimise waste and enhance operational efficiency in clinical and diagnostic areas.

What Are the Key Segments in the In Vitro Diagnostic Packaging Market?
The in vitro diagnostic packaging market covered in this report is segmented -

1) By Packaging Type: Primary Packaging, Secondary Packaging, Tertiary Packaging
2) By Product: Bottles And Vials, Tubes, Petri Dishes, Closures, Other Products
3) By Material Type: Plastic, Glass, Metal, Composite Materials
4) By Application Area: Biochemistry, Microbiology, Immunology, Molecular Diagnostics
5) By End User: Hospitals, Laboratories, Academic Institutes, Other End Users

Subsegments:
1) By Primary Packaging: Cartridges, Microplates, Sample Collection Containers, Reagent Reservoirs, Diagnostic Cassettes, Dropper Bottles
2) By Secondary Packaging: Folding Cartons, Paperboard Sleeves, Trays, Multi-Compartment Boxes, Label Sets, Instruction Leaflets
3) By Tertiary Packaging: Corrugated Shipping Boxes, Pallets, Insulated Shippers, Foam Inserts Or Cushioning, Tamper-Evident Seals, Bulk Transport Containers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24250&type=smp

Who Are the Key Players Shaping the In Vitro Diagnostic Packaging Market's Competitive Landscape?
Major companies operating in the in vitro diagnostic packaging market are Thermo Fisher Scientific Inc., Siemens Healthineers, Amcor plc., Corning Incorporated, Intertek Group plc, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., ProAmpac, DiaSorin S.p.A., Stevanato Group S.p.A., Sarstedt AG & Co. KG, Greiner AG, Phillips Medisize, Scantibodies Laboratory Inc., Sanner GmbH, DWK Life Sciences, MML Diagnostics Packaging Inc., TCS Biosciences Ltd, Narang Medical Limited, Thousand Peak Glass Bottle CO.LTD.

What Geographic Markets Are Powering Growth in the In Vitro Diagnostic Packaging Market?
North America was the largest region in the in vitro diagnostic packaging market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostic packaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24250

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.